Skip to Content
 

Prostate cancer care in spotlight at first VU football game

September 3, 2015 | Dagny Stuart

SEC-Slive-prostate-logo-250x250In the first game of the season, Vanderbilt’s football program, in conjunction with the Southeastern Conference, is kicking off a campaign to highlight prostate cancer prevention and awareness. During the Sept. 3 home opener against Western Kentucky University, the Commodores are slated to wear commemorative helmet stickers to raise awareness about the disease. Other awareness activities will take place during the game, which kicks off at 7 p.m. in Vanderbilt Stadium. The game will be televised on the SEC network.

The Southeastern Conference launched the campaign to honor former commissioner Mike Slive, who coped with the disease during his administrative career. The 14 Athletics Directors of the SEC voted unanimously in May to recognize Slive by dedicating games in his honor. The Prostate Cancer Awareness Games are scheduled on each of the 14 league campuses during the month of September.

Prostate cancer is the second leading cause of cancer death among American men. Although the disease is serious, most men diagnosed with prostate cancer can successfully fight the disease with early detection. Men over the age of 50 are encouraged to talk with their physicians about their risk for the disease and their options for screening.

Slive was originally diagnosed with prostate cancer in the late 1990s. In October 2014, he announced he was dealing with a recurrence of his prostate cancer and stepped down at the end of the year after serving as commissioner for 13 years. He has been undergoing treatment periodically and plans to attend several of the games during the month of September.

Vanderbilt-Ingram Cancer Center experts are also onboard for this important awareness and prevention campaign. VICC provides multidisciplinary care for men seeking information, screening options and leading-edge treatment for prostate cancer.

VICC’s prostate cancer experts include imaging specialists, urologic surgeons, pathologists, radiation oncologists, medical oncologists and hematologist/oncologists who work together as a comprehensive team to provide high-quality evidence-based care for patients. Members of this team are renowned for their research studies which are routinely published in many of the leading academic medical journals.

Men who want to know more about their risks for prostate cancer or who are seeking care may schedule an appointment at VICC by calling toll free 1-877-936-8422.